BRUCE E LEVIN
Vehicle Board in Philadelphia, PA

6432986, Aug 13, 2002

Jul 17, 1998

09/118615

Bruce H. Levin - Philadelphia PA 19106

A61K 31445

514330, 514310, 514607, 424 28, 424 49, 424 47

Methods, kits, and compositions for inhibiting a cerebral neurovascular disorder or a muscular headache in a human patient are provided. The methods comprise intranasally administering to the patient a pharmaceutical composition comprising a local anesthetic, and preferably a long-acting local anesthetic ingredient. A composition useful for practicing the methods of the invention is described which comprises at least one local anesthetic in a pharmaceutically acceptable carrier, wherein the composition is formulated for intranasal delivery. Cerebral neurovascular disorders include migraine and cluster headache. Muscular headaches include tension headaches and muscle contraction headaches. A kit comprising the composition and an intranasal applicator and a method of systemically delivering a pharmaceutically active agent to an animal are also included in the invention.

8224438, Jul 17, 2012

Jan 6, 2010

12/683301

Bruce H. Levin - Philadelphia PA, US

A61N 1/00

607 2

Methods, kits, apparatus, and compositions for inhibiting a cerebral neurovascular disorder, a muscular headache, or cerebral inflammation in a human patient are provided. The methods comprise intranasally administering to the patient a pharmaceutical composition comprising a local anesthetic, and preferably a long-acting local anesthetic ingredient. A composition useful for practicing the methods of the invention is described which comprises at least one local anesthetic in a pharmaceutically acceptable carrier, wherein the composition is formulated for intranasal delivery. Cerebral neurovascular disorders include migraine and cluster headache. Muscular headaches include tension headaches and muscle contraction headaches. A kit comprising the composition and an intranasal applicator and a method of systemically delivering a pharmaceutically active agent to an animal are also included in the invention. Apparatus for directed intranasal administration of the compositions of the invention and for performing the methods of the invention are also described.

2007002, Jan 25, 2007

Sep 25, 2006

11/526946

Bruce Levin - Philadelphia PA, US

A61K 38/48, A61L 15/00, A61K 9/127, A61K 31/24

424094630, 424450000, 514537000, 424445000

Compositions useful for treating inflammatory diseases including arthritis are disclosed which comprise cetyl myristoleate compounds or related compounds and at least one compound useful for treatment of inflammatory disease, such as tetracycline compounds, Cox-2 inhibitors, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, local anaesthetics, chelating agents, matrix metalloprotease inhibitors, inhibitors of inflammatory cytokines, glucosamine, chondroitin sulfate and collagen hydrolysate. Also disclosed are pharmaceutical compositions and methods of treatment for inflammatory disease and local inflammation and dermal irritation. Also disclosed are compositions including tetracycline and at least one compound useful for treatment of inflammatory disease.

2008021, Sep 11, 2008

Feb 11, 2008

12/029174

Bruce LEVIN - Philadelphia PA, US

A61B 19/00

128898

The invention relates to methods and instruments for relieving spinal nerve impingement disorders (SNIDs) and symptoms associated with SNIDs. The methods involve separating a spinal neural structure and a transforaminal or peliforaminal ligament.

2008023, Sep 25, 2008

Oct 30, 2007

11/978990

Bruce Levin - Philadelphia PA, US

G08B 13/14

3405721

A system and method of tracking medical products provides for associating a group of medical products with a group location based on a group radio frequency identification (RF ID) device signal, where the group includes a first unit and a second unit. The first unit is associated with a first remote location based on a first unit RF ID device signal. The method further provides for associating the second unit with a second remote location based on a second unit RF ID device signal. The signals uniquely identify the units and the group.